MENU

RGLS Regulus Therapeutics Forecast, Technical & Fundamental Analysis

a developer of pharmaceutical products

Industry Biotechnology
RGLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
RGLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

RGLS is expected to report earnings to fall 17.95% to -17 cents per share on March 20

Regulus Therapeutics RGLS Stock Earnings Reports
Q4'24
Est.
$-0.17
Q3'24
Missed
by $0.04
Q2'24
Missed
by $0.05
Q1'24
Missed
by $0.07
Q4'23
Est.
$-0.40
The last earnings report on November 07 showed earnings per share of -20 cents, missing the estimate of -17 cents. With 105.53K shares outstanding, the current market capitalization sits at 106.11M.
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
4224 Campus Point Court
Phone
+1 858 202-6300
Employees
30
Web
https://www.regulusrx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

RGLS and Stocks

Correlation & Price change

A.I.dvisor tells us that RGLS and NAUT have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RGLS and NAUT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGLS
1D Price
Change %
RGLS100%
-1.22%
NAUT - RGLS
28%
Poorly correlated
-1.00%
SPRY - RGLS
26%
Poorly correlated
-1.05%
SLNCF - RGLS
25%
Poorly correlated
N/A
CYDY - RGLS
24%
Poorly correlated
-1.62%
BMNDF - RGLS
23%
Poorly correlated
N/A
More